Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -361.91% is 196% below its 5-year average of -122.23%, around the middle of its 5-year range (-589.63%–22.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.93% above its 12-month average of -475.77%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -361.91%.
RETURN ON EQUITY (ROE)
-361.91%
RETURN ON EQUITY (ROE) AVG TTM
-475.77%
RETURN ON EQUITY (ROE) AVG 3Y
-230.00%
RETURN ON EQUITY (ROE) AVG 5Y
-122.23%
RETURN ON EQUITY (ROE) AVG 10Y
-131.21%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.93%
CURRENT VS 3Y AVG
-57.35%
CURRENT VS 5Y AVG
-196.08%
CURRENT VS 10Y AVG
-175.82%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-761.48%
vs the sector median at left
Precigen, Inc.
Market Cap
$2.72B
Return on Equity (ROE)
-361.91%
TTM Avg
-475.77%
3Y Avg
-230.00%
5Y Avg
-122.23%
Market Cap
$2.77B
Return on Equity (ROE)
2.04%
TTM Avg
-6.01%
3Y Avg
-7.18%
5Y Avg
-5.00%
Market Cap
$2.68B
Return on Equity (ROE)
-56.91%
TTM Avg
-24.13%
3Y Avg
-9.83%
5Y Avg
-11.19%
Market Cap
$2.80B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$2.65B
Return on Equity (ROE)
95.64%
TTM Avg
115.72%
3Y Avg
76.74%
5Y Avg
3213.80%
Market Cap
$2.65B
Return on Equity (ROE)
-25.47%
TTM Avg
-23.80%
3Y Avg
14.67%
5Y Avg
14.67%
Market Cap
$2.61B
Return on Equity (ROE)
-0.38%
TTM Avg
-26.55%
3Y Avg
-13.53%
5Y Avg
-6.91%
Market Cap
$2.60B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$2.58B
Return on Equity (ROE)
0.00%
TTM Avg
2.68%
3Y Avg
1.94%
5Y Avg
-2.51%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precigen, Inc. (PGEN) | $2.72B | -361.91% | -475.77% | -230.00% | -122.23% |
| AtriCure, Inc. (ATRC)vs › | $2.77B | 2.04% | -6.01% | -7.18% | -5.00% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | -56.91% | -24.13% | -9.83% | -11.19% |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 29.28% | 27.86% | 4.54% | -12.45% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 95.64% | 115.72% | 76.74% | 3213.80% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.65B | -25.47% | -23.80% | 14.67% | 14.67% |
| Neogen Corporation (NEOG)vs › | $2.61B | -0.38% | -26.55% | -13.53% | -6.91% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -8.00% | -28.91% | -27.68% | -39.13% |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | 0.00% | 2.68% | 1.94% | -2.51% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.90B | -73.97% | -48.15% | -105.34% | -79.84% |
ROE
-361.9%
ROA
-92.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -361.91% |
| 2025-09-30 | -589.63% |
| 2024-12-31 | -327.77% |
| 2024-09-30 | -252.03% |
| 2024-06-30 | -313.60% |
| 2024-03-31 | -99.89% |
| 2023-12-31 | -80.93% |
| 2023-09-30 | -57.57% |
| 2023-06-30 | 13.33% |
| 2023-03-31 | 13.49% |
| 2022-12-31 | 22.43% |
| 2022-09-30 | 17.86% |
| 2022-06-30 | -164.74% |
| 2022-03-31 | -127.44% |
| 2021-12-31 | -85.86% |
| 2021-09-30 | -82.89% |
| 2021-06-30 | -68.18% |
| 2021-03-31 | -75.43% |
| 2020-12-31 | -254.85% |
| 2020-09-30 | -510.23% |
| 2020-06-30 | -651.72% |
| 2020-03-31 | -364.88% |
| 2019-12-31 | -449.48% |
| 2019-09-30 | -216.08% |
| 2019-06-30 | -178.09% |
| 2019-03-31 | -167.36% |
| 2018-12-31 | -139.22% |
| 2018-09-30 | -35.59% |
| 2018-06-30 | -31.71% |
| 2018-03-31 | -23.07% |
| 2017-12-31 | -21.93% |
| 2017-09-30 | -25.09% |
| 2017-06-30 | -22.36% |
| 2017-03-31 | -29.06% |
| 2016-12-31 | -33.31% |
| 2016-09-30 | -29.18% |
| 2016-06-30 | -29.78% |
| 2016-03-31 | -26.47% |
| 2015-12-31 | -12.17% |
| 2015-09-30 | -4.59% |
| 2015-06-30 | -10.00% |
| 2015-03-31 | -9.18% |
| 2014-12-31 | -21.27% |
| 2014-09-30 | -31.49% |
| 2014-06-30 | -11.97% |
| 2014-03-31 | 0.32% |
| 2013-12-31 | -10.66% |
| 2013-09-30 | -15.33% |
| 2013-03-31 | -92.55% |
